| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys
|
Kang, Ciming
|
|
2017
|
9 |
1 |
p. 130-134
|
article
|
| 2 |
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
|
Tsuchikama, Kyoji
|
|
2016
|
9 |
1 |
p. 33-46
|
article
|
| 3 |
Current progress in innovative engineered antibodies
|
Strohl, William R.
|
|
2017
|
9 |
1 |
p. 86-120
|
article
|
| 4 |
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
|
Tan, Shuguang
|
|
2017
|
9 |
1 |
p. 135-139
|
article
|
| 5 |
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
|
Mimura, Yusuke
|
|
2017
|
9 |
1 |
p. 47-62
|
article
|
| 6 |
IgG Fc engineering to modulate antibody effector functions
|
Wang, Xinhua
|
|
2017
|
9 |
1 |
p. 63-73
|
article
|
| 7 |
In vitro-engineered non-antibody protein therapeutics
|
Simeon, Rudo
|
|
2017
|
9 |
1 |
p. 3-14
|
article
|
| 8 |
“Magic Bullets” at the center stage of immune therapy: a special issue on therapeutic antibodies
|
An, Zhiqiang
|
|
2017
|
9 |
1 |
p. 1-2
|
article
|
| 9 |
Molecular and functional analysis of monoclonal antibodies in support of biologics development
|
Wang, Xin
|
|
2017
|
9 |
1 |
p. 74-85
|
article
|
| 10 |
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
|
Liu, Liming
|
|
2017
|
9 |
1 |
p. 15-32
|
article
|
| 11 |
Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig
|
Bardwell, Philip D.
|
|
2017
|
9 |
1 |
p. 121-129
|
article
|
Journal description